Mergers and acquisitions

Skate where the puck is going to be: Coming to terms with the top three issues facing Life Sciences today

Posted by Ian Wilcox

As human resources and operations leaders from around the world gather in Boston for the annual Hanson Wade Life Sciences Leadership Forum, I see three pressing issues that will pose major challenges to the industry over the coming years. The … Continue reading

Pharma deals don’t have to threaten innovation

Posted by Ian Wilcox

In pharma, the big story of the spring and summer has been M&A. The drama began in April with an asset swap between GSK and Novartis. The most recent headline grabbers have been inversion deals like AbbVie’s $54 billion acquisition … Continue reading

Five people-focused strategies for getting the most from your M&A

Posted by Ian Wilcox

Last week, I made the case that in an M&A deal, you need to pay close attention to the people components—not just financials. Today I want to share five people-focused strategies for maximizing M&A value over the long term. Understand … Continue reading

Better together? Why a focus on alignment is a precondition for ‘transformative’ M&A

Posted by David Derain

By David Derain and Frédéric L’Héréec Every merger or acquisition faces two parallel challenges – bringing the businesses together, while at the same time maintaining continuity. To achieve this, companies typically form a program management office (PMO, also known as … Continue reading

M&As: a match made in heaven?

Posted by David Derain

It’s no secret that mergers and acquisitions (M&A) are a risky business. From the boardroom to the negotiation table right through to integration, the M&A process gives plenty of opportunities for Murphy’s Law: the worst things will happen at the … Continue reading


Subscribe to our mailing list now!

To access our latest thinking and get regular updates fill in your email address below

Latest video blog

More from Hay Group